Editas Medicine (EDIT) Operating Margin (QoQ) (2015 - 2025)

Editas Medicine (EDIT) Operating Margin (QoQ) (2015 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Editas Medicine 245.95 Mn 99.30 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 111,514.00
Jun 30, 2025 19,452.00
Mar 31, 2025 -148,286.00
Dec 31, 2024 10.75 Mn
Sep 30, 2024 -9.36 Mn
Jun 30, 2024 -811,389.00
Mar 31, 2024 -586,239.00
Dec 31, 2023 90,018.00
Sep 30, 2023 58,724.00
Jun 30, 2023 -101,001.00
Mar 31, 2023 45,340.00
Dec 31, 2022 13.60 Mn
Sep 30, 2022 -13.61 Mn
Jun 30, 2022 -10,295.00
Mar 31, 2022 -41,581.00
Dec 31, 2021 29,971.00
Sep 30, 2021 1.40 Mn
Jun 30, 2021 -1.37 Mn
Mar 31, 2021 -29,839.00
Dec 31, 2020 -59,117.00